Status | Study |
Recruiting |
Study Name: Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Condition: Primary Effusion Lymphoma B-Cell Lymphoma Date: 2016-09-21 Interventions: Drug: Lenalidomide Lenalidomid |
Suspended |
Study Name: Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma Condition: AIDS-Related Hodgkin Lymphoma AIDS-Related Non-Hodgkin Lymphoma Date: 2015-02-27 Interventions: Biological: Gene-Modified HIV-Protected Hematopoietic Stem Cells |
Recruiting |
Study Name: Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma Condition: AIDS-related Diffuse Large Cell Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma Date: 2013-01-23 Interventions: Drug: cyclophosphamide Given I |
Withdrawn |
Study Name: Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma Condition: Adult Nasal Type Extranodal NK/T-cell Lymphoma AIDS-related Diffuse Large Cell Lymphoma Date: 2013-01-15 Interventions: Drug: carmustine Given IV |
Completed |
Study Name: High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk Condition: HIV-related Lymphoma HIV Infections Date: 2010-01-08 Interventions: Other: Rituximab and CHOP regimen + PBSCT Other Names: Mabthera |
Active, not recruiting |
Study Name: Cohort of HIV Associated Lymphomas Condition: HIV Infection Date: 2009-12-22 |
Recruiting |
Study Name: 124I-FIAU Imaging in EBV and KSHV Associated Cancers Condition: Hodgkin Lymphoma Non Hodgkin Lymphoma Kaposi's Sarcoma Date: 2009-09-22 Interventions: Other: FIAU-PET-CT scans 1-3 d |
Suspended |
Study Name: High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT Condition: AIDS-related Lymphoma HIV Infections Date: 2009-03-09 Interventions: Procedure: PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC) Patient stem |
Recruiting |
Study Name: Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Condition: Bladder Cancer Brain and Central Nervous System Tumors Eso Date: 2008-09-22 Interventions: Genetic: DNA analysis Genetic: polymorphis |
Active, not recruiting |
Study Name: Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma Condition: Lymphoma Date: 2008-03-21 Interventions: Drug: carmustine 150 mg/m2 day |